journal article·2024-12-31Open access

A review on dendrimer-based nanoconjugates and their intracellular trafficking in cancer photodynamic therapy

Lufuno Nemakhavhani, Heidi Abrahamse, Sathish Sundar Dhilip Kumar

Abstract

Nanotechnology-based cancer treatment has received considerable attention, and these treatments generally use drug-loaded nanoparticles (NPs) to target and destroy cancer cells. Nanotechnology combined with photodynamic therapy (PDT) has demonstrated positive outcomes in cancer therapy. Combining nanotechnology and PDT is effective in targeting metastatic cancer cells. Nanotechnology can also increase the effectiveness of PDT by targeting cells at a molecular level. Dendrimer-based nanoconjugates (DBNs) are highly stable and biocompatible, making them suitable for drug delivery applications. Moreover, the hyperbranched structures in DBNs have the capacity to load hydrophobic compounds, such as photosensitizers (PSs) and chemotherapy drugs, and deliver them efficiently to tumour cells. This review primarily focuses on DBNs and their potential applications in cancer treatment. We discuss the chemical design, mechanism of action, and targeting efficiency of DBNs in tumour metastasis, intracellular trafficking in cancer treatment, and DBNs' biocompatibility, biodegradability and clearance properties. Overall, this study will provide the most recent insights into the application of DBNs and PDT in cancer therapy.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Dendrimers and Hyperbranched Polymers · Gold and Silver Nanoparticles Synthesis and Applications

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Laser Research Centre, University of Johannesburg, Johannesburg, South Africa

Funding

South African Research Chairs Initiative of the Department of Science and Technology · National Research Foundation of South Africa · University of Johannesburg · National Research Foundation · CSIR (Council for Scientific and Industrial Research) – NLC (National Laser Centre) Laser Rental Pool Programme · South African Medical Research Council · Self-Initiated Research Grant

References (100+)

Show source-provided references
1. World Health Organization. Cancer; 2022 [cited 2023 Mar 17]. Available from: https://www.who.int/news-room/fact-sheets/detail/cancer
2. Hobbs H. Cancer: types cause prevention and more. In: Healthline cancer: types causes treatment and prevention; 2022 [cited 2022 May 22]. Available from: healthline.com
3. 10.1038/nrc.2017.610.1038/nrc.2017.6 ↗
4. 10.1016/j.clindermatol.2012.08.01610.1016/j.clindermatol.2012.08.016 ↗
5. 10.1177/153303381879179510.1177/1533033818791795 ↗
6. 10.2174/156802662166621070114412410.2174/1568026621666210701144124 ↗
7. 10.1021/acs.jmedchem.1c0108010.1021/acs.jmedchem.1c01080 ↗
8. 10.1021/acs.bioconjchem.8b0057410.1021/acs.bioconjchem.8b00574 ↗
9. 10.1021/acsabm.2c0037310.1021/acsabm.2c00373 ↗
10. 10.1016/j.eurpolymj.2021.11068310.1016/j.eurpolymj.2021.110683 ↗
11. 10.1021/acsbiomaterials.9b0138610.1021/acsbiomaterials.9b01386 ↗
12. 10.3390/ma1301006510.3390/ma13010065 ↗
13. 10.1186/s13058-016-0740-210.1186/s13058-016-0740-2 ↗
14. 10.1016/j.nano.2020.10231710.1016/j.nano.2020.102317 ↗
15. Alyssa Owens Manasi Godbole Donnette Dabydeen Lori Medeiros Pradyumna Phatak Satish Kandlikar. Conference Proceedings of the Xth Conference on Nanochannels Microchannels and Minichannels. American Society of Mechanical Engineers; Conference date: 13-15 July 2020. United States of America (Virtual online): New York City. 2020.
16. 10.1007/s00330-012-2724-710.1007/s00330-012-2724-7 ↗
17. 10.1038/modpathol.2016.22710.1038/modpathol.2016.227 ↗
18. 10.1021/mp500765e10.1021/mp500765e ↗
19. 10.1101/gad.211326.11210.1101/gad.211326.112 ↗
20. 10.1038/s41392-023-01347-110.1038/s41392-023-01347-1 ↗
21. 10.1093/nar/gks93710.1093/nar/gks937 ↗
22. 10.1021/jacs.2c1040910.1021/jacs.2c10409 ↗
23. Umoren SA Solomon MM Saji VS. Polymeric materials in corrosion inhibition: fundamentals and applications. San Diego: Elsevier; 2022.10.1016/B978-0-12-823854-7.00026-6 ↗
24. Karandikar S Mirani A Waybhase V et al. Nanovaccines for oral delivery—formulation strategies and challenges. In: Ecaterina Andronescu Alexandru Grumezesc (editors) Nanostructures for oral medicine. Amsterdam: Elsevier; 2017. p. 263–293.10.1016/B978-0-323-47720-8.00011-0 ↗
25. 10.1021/acs.langmuir.8b0116910.1021/acs.langmuir.8b01169 ↗
26. 10.3390/molecules2517398210.3390/molecules25173982 ↗
27. 10.3390/pharmaceutics1202017110.3390/pharmaceutics12020171 ↗
28. 10.3390/molecules2209140110.3390/molecules22091401 ↗
29. 10.1186/1556-276X-9-24710.1186/1556-276X-9-247 ↗
30. 10.1021/acs.nanolett.2c0150910.1021/acs.nanolett.2c01509 ↗
31. 10.1186/s13036-022-00298-510.1186/s13036-022-00298-5 ↗
32. 10.3390/macromol302002210.3390/macromol3020022 ↗
33. 10.1007/s10904-021-01925-210.1007/s10904-021-01925-2 ↗
34. 10.1021/la503956h10.1021/la503956h ↗
35. 10.1088/2043-6254/aa5e3210.1088/2043-6254/aa5e32 ↗
36. 10.1016/j.ijpharm.2016.10.01510.1016/j.ijpharm.2016.10.015 ↗
37. 10.1021/am508760w10.1021/am508760w ↗
38. 10.1039/C9TB02289A10.1039/C9TB02289A ↗
39. 10.1002/btm2.1000310.1002/btm2.10003 ↗
40. 10.1021/acsnano.7b0308810.1021/acsnano.7b03088 ↗
41. 10.1021/nn500299p10.1021/nn500299p ↗
42. 10.1016/j.apsb.2019.08.00310.1016/j.apsb.2019.08.003 ↗
43. 10.1021/acs.nanolett.9b0391310.1021/acs.nanolett.9b03913 ↗
44. 10.1021/acsnano.5b0201710.1021/acsnano.5b02017 ↗
45. 10.1186/s40824-021-00226-610.1186/s40824-021-00226-6 ↗
46. Jain KK. An overview of drug delivery systems. In: Kewal K. Jain (editor) Drug delivery systems; 2020. Springer nature: New York. p. 1–54.10.1007/978-1-4939-9798-5_1 ↗
47. 10.1208/s12248-015-9814-910.1208/s12248-015-9814-9 ↗
48. 10.1016/j.ajps.2023.10077510.1016/j.ajps.2023.100775 ↗
49. 10.3390/pharmaceutics704043810.3390/pharmaceutics7040438 ↗
50. 10.1517/17425247.2014.87552810.1517/17425247.2014.875528 ↗
51. 10.1016/S1773-2247(14)50041-X10.1016/S1773-2247(14)50041-X ↗
52. 10.2147/PPA.S8727110.2147/PPA.S87271 ↗
53. 10.3390/pharmaceutics1412278310.3390/pharmaceutics14122783 ↗
54. 10.1021/acs.jmedchem.2c0183710.1021/acs.jmedchem.2c01837 ↗
55. 10.1016/j.jddst.2020.10217810.1016/j.jddst.2020.102178 ↗
56. 10.1038/s12276-018-0126-x10.1038/s12276-018-0126-x ↗
57. 10.1007/s00018-012-1070-x10.1007/s00018-012-1070-x ↗
58. Singh AK Sharma AK Khan I et al. Oral drug delivery potential of dendrimers. In: Ecaterina Andronescu & Alexandru Mihai Grumezescu (editors) Nanostructures for oral medicine. Amsterdam: Elsevier; 2017. p. 231–261.10.1016/B978-0-323-47720-8.00010-9 ↗
59. 10.1016/j.apmt.2018.05.00210.1016/j.apmt.2018.05.002 ↗
60. 10.1016/j.bbamem.2012.09.01610.1016/j.bbamem.2012.09.016 ↗
61. 10.2174/187446721366620073011494310.2174/1874467213666200730114943 ↗
62. 10.1016/j.sciaf.2020.e0068510.1016/j.sciaf.2020.e00685 ↗
63. 10.1186/s12951-023-01826-110.1186/s12951-023-01826-1 ↗
64. 10.1016/j.addr.2013.11.00910.1016/j.addr.2013.11.009 ↗
65. 10.1111/jphp.1309810.1111/jphp.13098 ↗
66. 10.1021/acs.jmedchem.9b0051110.1021/acs.jmedchem.9b00511 ↗
67. 10.3390/molecules2410187310.3390/molecules24101873 ↗
68. 10.1007/s10311-020-01022-910.1007/s10311-020-01022-9 ↗
69. 10.3390/jpm1102012410.3390/jpm11020124 ↗
70. 10.1016/j.ejps.2012.12.00610.1016/j.ejps.2012.12.006 ↗
71. 10.1016/j.addr.2017.07.01010.1016/j.addr.2017.07.010 ↗
72. 10.1016/j.apsb.2021.03.03310.1016/j.apsb.2021.03.033 ↗
73. 10.1073/pnas.181293811510.1073/pnas.1812938115 ↗
74. 10.1038/nrc.2016.10810.1038/nrc.2016.108 ↗
75. 10.1021/acs.chemrev.8b0040110.1021/acs.chemrev.8b00401 ↗
76. 10.1002/adfm.20190928510.1002/adfm.201909285 ↗
77. 10.1007/s40843-018-9271-410.1007/s40843-018-9271-4 ↗
78. 10.4103/1673-5374.16006310.4103/1673-5374.160063 ↗
79. 10.2147/IJN.S27428910.2147/IJN.S274289 ↗
80. 10.1016/j.ijpharm.2018.04.02710.1016/j.ijpharm.2018.04.027 ↗
81. 10.1021/am504849x10.1021/am504849x ↗
82. Dey A.D. Bigham A. Esmaeili Y. Ashrafizadeh M. Moghaddam F.D. Tan S.C. Yousefiasl S. Sharma S. Maleki A. Rabiee N. Kumar A.P. Thakur V.K. Orive G. Sharifi E. Kumar A. & Makvandi P. 2022. Dendrimers as nanoscale vectors: Unlocking the bars of cancer therapy. Seminars in cancer biology 86396-419.10.1016/j.semcancer.2022.06.003 ↗
83. 10.2147/IJN.S10641810.2147/IJN.S106418 ↗
84. 10.1038/s41598-019-50424-510.1038/s41598-019-50424-5 ↗
85. 10.1021/acsami.5b0209510.1021/acsami.5b02095 ↗
86. 10.2217/nnm-2019-028810.2217/nnm-2019-0288 ↗
87. 10.1007/s40843-018-9323-610.1007/s40843-018-9323-6 ↗
88. 10.1021/acsbiomaterials.8b0164110.1021/acsbiomaterials.8b01641 ↗
89. 10.1021/acsapm.2c0131610.1021/acsapm.2c01316 ↗
90. 10.1016/j.jconrel.2021.07.01810.1016/j.jconrel.2021.07.018 ↗
91. 10.1016/j.eurpolymj.2021.11049110.1016/j.eurpolymj.2021.110491 ↗
92. 10.4172/2157-7439.100039310.4172/2157-7439.1000393 ↗
93. 10.1186/s12951-020-00695-210.1186/s12951-020-00695-2 ↗
94. 10.3390/biom1009133110.3390/biom10091331 ↗
95. 10.1002/adhm.20180010610.1002/adhm.201800106 ↗
96. Ouyang Z Li D Shen M et al. Dendrimer-based tumor-targeted systems. In: Rongqin Huang & Yi Wang (editors) New nanomaterials and techniques for tumor-targeted systems; Springer: Singapore 2020. p. 337–369.10.1007/978-981-15-5159-8_10 ↗
97. 10.1002/adhm.20160092310.1002/adhm.201600923 ↗
98. 10.1039/C7RA00713B10.1039/C7RA00713B ↗
99. 10.1016/j.actbio.2017.04.02310.1016/j.actbio.2017.04.023 ↗
100. 10.1021/acsami.0c2162010.1021/acsami.0c21620 ↗